Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 41,165	$ 40,484
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,719	6,080
Net amortization (accretion) of premiums (discounts) on securities	2,014	(2,681)
(Benefit) provision for credit losses	(311)	8,410
Share-based compensation	1,809	1,929
Deferred income tax expense (benefit)	1,094	(486)
Proceeds from sale of loans held for sale	34,491	12,983
Originations of loans held for sale	(35,184)	(13,957)
Income on company owned life insurance	(4,062)	(2,974)
Net gain on sale of loans held for sale	(432)	(349)
Net gain on sale of assets of subsidiary	(13,658)	0
Net loss (gain) on other assets	25	(31)
Non-cash restructuring recoveries against assets	0	(74)
Decrease (increase) in other assets	31,113	(26,976)
(Decrease) increase in other liabilities	(13,672)	36,205
Net cash provided by operating activities	50,111	58,563
Cash flows from investing activities:
Purchases of available for sale securities	(131,401)	0
Purchases of held to maturity securities	(1,059)	(1,638)
Proceeds from principal payments, maturities and calls on available for sale securities	155,734	68,317
Proceeds from principal payments, maturities and calls on held to maturity securities	27,772	36,702
Net decrease (increase) in loans	53,242	(385,040)
Net proceeds from company owned life insurance	1	255
Proceeds from sale of assets of subsidiary	27,000	0
Purchases of premises and equipment	(4,571)	(1,739)
Net cash provided by (used in) investing activities	126,718	(283,143)
Cash flows from financing activities:
Net increase in deposits	93,689	386,549
Net decrease in short-term borrowings	(130,000)	(135,000)
Proceeds from long-term borrowings	0	50,000
Purchases of common stock for treasury	(422)	(563)
Cash dividends paid to common and preferred shareholders	(14,969)	(14,761)
Net cash (used in) provided by financing activities	(51,702)	286,225
Net increase in cash and cash equivalents	125,127	61,645
Cash and cash equivalents, beginning of period	124,442	130,466
Cash and cash equivalents, end of period	$ 249,569	$ 192,111